Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSB0800072	注射用重组改构人肿瘤坏死因子	recombinant mutant human tumor necrosis factor	Lyophilized	Biological Products	Supplementary Application	2008-11-20	上海复旦生物工程有限公司	Shanghai Fudan Bio-Engineering Co Ltd	Certificate Issued	2009-05-05	view
CSS20020013	注射用重组人肿瘤坏死因子α衍生物a		Lyophilized	Biological Products(1)	New Drug Application	2002-03-12	上海复旦生物工程有限公司	Shanghai Fudan Bio-Engineering Co Ltd	Approval Completed-Pending Certificated	2003-07-18	view